
NanoTalks
- M.A Esteve
- 11/03/2025
The Impact of Passive and Active Targeting in Nanoparticles
Discover how Passive and Active Targeting are transforming nanoparticle drug delivery by enhancing specificity, efficacy, and therapeutic outcomes. Understanding the mechanisms behind these strategies is essential for optimizing drug formulation and ensuring targeted delivery to diseased tissues. In this post, we break down the key differences between Passive and Active Targeting, explore their advantages and challenges, and highlight expert insights on conjugation methods that improve ligand attachment and stability. Whether you’re developing next-generation nanoparticles or refining your drug delivery approach, this deep dive will provide valuable guidance on maximizing the potential of targeted therapies.

Recent Articles
- Samuel García
- March 20, 2025
- Miguel Ángel Esteve
- March 11, 2025
- Miguel Ángel Esteve
- March 4, 2025
- Miguel Ángel Esteve
- February 10, 2025
- Miguel Ángel Esteve
- February 10, 2025
Sign Up for NanoTalks
Subscribe to NanoTalks, the magazine of Curapath. Stay up to date on the latest developments, trends and news in the world of non-viral vectors, plus discover the latest advances in nanobiotechnology.